A Novel Acetylation-Immune Subtyping for the Identification of a BET Inhibitor-Sensitive Subgroup in Melanoma
Background: There have been significant advancements in melanoma therapies. BET inhibitors (BETis) show promise in impairing melanoma growth. However, identifying BETi-sensitive melanoma subtypes is challenging. Methods and Results: We analyzed 48 melanoma cell lines and 104 patients and identified...
Main Authors: | Liuying Wang, Liuchao Zhang, Shuang Li, Lei Cao, Kang Li, Weiwei Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/7/1037 |
Similar Items
-
Bromodomain Protein Inhibitors Reorganize the Chromatin of Synovial Fibroblasts
by: Monika Krošel, et al.
Published: (2023-04-01) -
Nε-Lysine Acetylation of the Histone-Like Protein HBsu Regulates the Process of Sporulation and Affects the Resistance Properties of Bacillus subtilis Spores
by: Jackson Luu, et al.
Published: (2022-01-01) -
Reversible protein acetylation /
by: Bock, Gregory, et al.
Published: (2004) -
Acetylation of histone H3 at lysine 64 regulates nucleosome dynamics and facilitates transcription
by: Vincenzo Di Cerbo, et al.
Published: (2014-03-01) -
Histone regulator KAT2A acts as a potential biomarker related to tumor microenvironment and prognosis of diffuse large B cell lymphoma
by: Zhuoya Yu, et al.
Published: (2023-10-01)